Clinical Trial Update: Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining the effects of romosozumab on bone density in women with anorexia nervosa; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Osteopenia

Drugs mentioned

• Evenity (romosozumab)

Snippet

Sponsor: Karen Klahr Miller, MD | Conditions: Bone Density, Low, Bone Loss | Phase 3 | Status: COMPLETED | Results posted: 2025-12-16